Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy
Clinical trial NCT02303977 · COMPLETED
Trial details
- NCT number
- NCT02303977
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-26
- Primary completion
- 2020-04-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.